News Pfizer's rituximab biosimilar gets late-stage trial boost Phase 3 success sets up showdown with Roche, Sandoz, and Celltrion
Events Partner Content BioTech Pharma Summit: Biosimilars & Biologics 2018 Biosimilars & Biologics:The future of Biotech Medicines
News Biocon and Sandoz strike biosimilars partnership Companies will develop and market several biosimilars
News Novartis files Humira biosimilar in US Novartis' Sandoz division has filed its biosimilar of Humira in the US, aiming to take a share of its multi-billion dollar revenues once its patent expires.
News Novartis tests Cosentyx against Humira and biosimilars Trials will cover psoriatic arthritis and ankylosing spondylitis
News Novo’s Ozempic among Europe’s drug recommendations Alongside the recommendation for what is set to be the first eve
News Isomorphic Labs raises $5bn in massive third round In yet another sign of the appetite for AI companies among investors, Isomorphic Labs has raised a whopping $5bn in a Series C financing.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.